analyst forecasts

DoorDash (DASH) Stock Today: Price, Fresh News, Analyst Forecasts and Outlook as of December 8, 2025

SAN FRANCISCO – December 8, 2025 – DoorDash, Inc. (NASDAQ: DASH) is back in the spotlight as the food‑delivery and local commerce giant juggles strong growth, ambitious global expansion, and a growing pile of legal and regulatory issues. On Monday,

8 December 2025

MercadoLibre (MELI) Stock Today: December 8, 2025 Update on Price, Q3 Results, Bond Deal and Analyst Forecasts

As of Monday, December 8, 2025, MercadoLibre, Inc. (NASDAQ: MELI) remains one of the most closely watched growth stocks in emerging markets. The Latin American e‑commerce and fintech leader is trading a little above $2,080 per share, giving it a

8 December 2025

Analyst Ratings · Earnings Reports · Financial News · Investing · Stock Market

Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is back in the spotlight. On December 8, 2025, the biotech stock surged roughly 20% intraday after the company released new Phase 1 data for its Bruton’s tyrosine kinase (BTK) degrader bexobrutideg (NX‑5948) in blood

8 December 2025

Biotech · Clinical Trials · Investment Analysis · Pharmaceuticals · Stock Market

Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally

Confluent, Inc. (NASDAQ: CFLT) has suddenly shifted from a high-growth data‑infrastructure story to a classic M&A arbitrage play. On December 8, 2025, IBM and Confluent announced a definitive agreement under which IBM will acquire all outstanding Confluent shares for $31

8 December 2025

Financial News · Investment Analysis · Mergers & Acquisitions · NASDAQ:CFLT · NYSE:IBM · Stock Market · Technology Industry

Structure Therapeutics (GPCR) Stock Soars on Obesity Pill Data: Latest News, Analyst Forecasts and 2026 Outlook (December 8, 2025)

Structure Therapeutics Inc. (NASDAQ: GPCR) just turned a long‑anticipated clinical readout into a full‑blown stock market event. On Monday, December 8, 2025, the company released positive topline data from its ACCESS program for aleniglipron (GSBR‑1290), a once‑daily oral GLP‑1 receptor

8 December 2025

Analyst Insights · Biotechnology · Investment News · Pharmaceutical Industry · Stock Market

Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals’ stock is back in the spotlight on 8 December 2025 after the company reported encouraging mid‑stage trial results for its AI‑discovered drug REC‑4881 in a rare, cancer‑linked condition called familial adenomatous polyposis (FAP). The news gives investors something

8 December 2025

Artificial Intelligence · Biotechnology · Clinical Trials · Pharmaceuticals · Stock Analysis

Strategy Inc (MSTR) Stock Today: Pre‑Market Outlook, New $962M Bitcoin Buy and Analyst Forecasts for December 8, 2025

Strategy Inc (NASDAQ: MSTR) — the Bitcoin‑heavy “Strategy Inc stock” many traders treat as a leveraged BTC proxy — is set for a lively session on Monday, December 8, 2025, after the company disclosed a fresh 10,624‑bitcoin purchase and updated

8 December 2025

Cryptocurrency · Financial Analysis · Investment Strategies · Market Forecasts · NASDAQ:MSTR · Stock Market

Carvana Stock Soars on S&P 500 Inclusion: CVNA Price, Outlook and Analyst Forecasts (December 8, 2025)

Updated: December 8, 2025 Carvana Co. (NYSE: CVNA) has completed one of Wall Street’s most dramatic comebacks. After trading below $4 in late 2022 and flirting with bankruptcy, the online used‑car retailer is now set to join the S&P 500

8 December 2025

Analyst Insights · Financial Forecasts · Investment Strategies · S&P 500 Updates · Stock Market News

Tesco Share Price Today: TSCO’s Buyback, Dividend Outlook and Analyst Forecasts as of 8 December 2025

Tesco PLC (LON: TSCO) heads into the key Christmas trading period with its share price hovering just below recent highs, a hefty share buyback underway and analysts broadly positive but no longer screaming “bargain”. As of the session on 8

8 December 2025

Dividend News · Financial Analysis · Investment · Stock Market · Tesco

Experian PLC (LON: EXPN) Stock on 8 December 2025: Price, Guidance Upgrade and Analyst Forecasts Into 2026

Experian PLC stock enters the second week of December trading just above £33 a share, against a backdrop of upgraded guidance, accelerating earnings and a sharply divided analyst community on how much upside is left. As of the close on

8 December 2025

Analyst Forecasts · Company News · Financial Analysis · Investment Insights · Stock Market

CapitaLand Investment (SGX:9CI) 2026 Outlook: Share Price, Latest News, Lodging Fund Close and Analyst Forecasts

CapitaLand Investment Limited (CLI) has spent 2025 quietly but aggressively rewiring itself into a fee-driven, asset‑light real estate investment manager with a strong Asia focus. As at 8 December 2025, its share price is still stuck around the S$2.60 mark,

8 December 2025

Analyst Forecasts · Financial News · Market Outlook · Real Estate Investment · Stock Analysis

Blackstone Inc (BX) Stock on December 7, 2025: Latest News, Analyst Forecasts and Outlook

Blackstone Inc (BX) Stock on December 7, 2025: Latest News, Analyst Forecasts and Outlook New York, December 7, 2025 — Blackstone Inc. (NYSE: BX), the world’s largest alternative asset manager, is ending the year with a flurry of activity that

7 December 2025

Analyst Forecasts · Financial News · Investment · Market Outlook · Stock Market